Literature DB >> 29800077

Subacute nodopathy with conduction blocks and anti-neurofascin 140/186 antibodies: an ultrastructural study.

Jean-Michel Vallat1, Stéphane Mathis2, Laurent Magy1, Pierre Bounolleau3, Marie Skarzynski4, Anne Heitzmann5, Constance Manso6, Jérôme Devaux7, Antonino Uncini8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29800077     DOI： 10.1093/brain/awy134

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  11 in total

1.  Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo.

Authors:  Constance Manso; Luis Querol; Cinta Lleixà; Mallory Poncelet; Mourad Mekaouche; Jean-Michel Vallat; Isabel Illa; Jérôme J Devaux
Journal:  J Clin Invest       Date:  2019-03-14       Impact factor: 14.808

Review 2.  Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.

Authors:  Lisha Tang; Qianyi Huang; Zhen Qin; Xiangqi Tang
Journal:  J Neurol       Date:  2020-04-07       Impact factor: 4.849

Review 3.  Nodes of Ranvier during development and repair in the CNS.

Authors:  Catherine Lubetzki; Nathalie Sol-Foulon; Anne Desmazières
Journal:  Nat Rev Neurol       Date:  2020-07-10       Impact factor: 42.937

Review 4.  Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations.

Authors:  Ze Wang; Xiajun Zhou; Nan Zhao; Chong Xie; Desheng Zhu; Yangtai Guan
Journal:  Neurol Sci       Date:  2021-03-29       Impact factor: 3.307

5.  Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy.

Authors:  Helena Stengel; Atay Vural; Anna-Michelle Brunder; Annika Heinius; Luise Appeltshauser; Bianca Fiebig; Florian Giese; Christian Dresel; Aikaterini Papagianni; Frank Birklein; Joachim Weis; Tessa Huchtemann; Christian Schmidt; Peter Körtvelyessy; Carmen Villmann; Edgar Meinl; Claudia Sommer; Frank Leypoldt; Kathrin Doppler
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-08-16

Review 6.  Impact of Neurofascin on Chronic Inflammatory Demyelinating Polyneuropathy via Changing the Node of Ranvier Function: A Review.

Authors:  Ying Gao; Lingxin Kong; Shan Liu; Kangding Liu; Jie Zhu
Journal:  Front Mol Neurosci       Date:  2021-12-16       Impact factor: 5.639

Review 7.  Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.

Authors:  Luis Querol; Cinta Lleixà
Journal:  Neurotherapeutics       Date:  2021-09-21       Impact factor: 7.620

8.  IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality.

Authors:  Janev Fehmi; Alexander J Davies; Jon Walters; Timothy Lavin; Ryan Keh; Alexander M Rossor; Tudor Munteanu; Norman Delanty; Rhys Roberts; Dirk Bäumer; Graham Lennox; Simon Rinaldi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-08-16       Impact factor: 10.154

9.  Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination.

Authors:  Stephanie Efthymiou; Vincenzo Salpietro; Nancy Malintan; Mallory Poncelet; Yamna Kriouile; Sara Fortuna; Rita De Zorzi; Katelyn Payne; Lindsay B Henderson; Andrea Cortese; Sateesh Maddirevula; Nadia Alhashmi; Sarah Wiethoff; Mina Ryten; Juan A Botia; Vincenzo Provitera; Markus Schuelke; Jana Vandrovcova; Laurence Walsh; Erin Torti; Valeria Iodice; Maryam Najafi; Ehsan Ghayoor Karimiani; Reza Maroofian; Karine Siquier-Pernet; Nathalie Boddaert; Pascale De Lonlay; Vincent Cantagrel; Mhammed Aguennouz; Mohamed El Khorassani; Miriam Schmidts; Fowzan S Alkuraya; Simon Edvardson; Maria Nolano; Jérôme Devaux; Henry Houlden
Journal:  Brain       Date:  2019-10-01       Impact factor: 13.501

10.  Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barré syndrome: Evidence for a nodo-paranodopathy.

Authors:  Céline Tard; Claude-Alain Maurage; Andre Maues de Paula; François Cassim; Arnaud Delval; Grégory Kuchcinski; Jean-Baptiste Davion; Luc Defebvre; Mohammed Bouchiba; Mercedes Jourdain; Joseph Boucraut
Journal:  Neurophysiol Clin       Date:  2020-10-08       Impact factor: 3.734
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.